ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
TLANDO & TLANDO XR - novel oral prodrugs of testosterone
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 231785" data-attributes="member: 13851"><p>Going to be a while!</p><p></p><p></p><p>[URL unfurl="true"]https://wfn1.com/financial-news/columns/zacks-research/lpcn-tlando-launched/[/URL]</p><p></p><p><strong>TLANDO</strong></p><p></p><p><em>Tlando was launched by partner <a href="https://halozyme.com/" target="_blank">Halozyme</a> during the second quarter, which acquired original license holder Antares Pharma in May 2022. Halozyme announced the launch of the product in a June 7th <a href="https://ir.halozyme.com/news/news-details/2022/Halozyme-Announces-Commercial-Launch-of-TLANDO-an-Oral-Treatment-for-Testosterone-Replacement-Therapy/default.aspx" target="_blank">press release </a>and plans to commercialize Tlando along with Antares’ injectable testosterone replacement therapy Xyosted. </em><strong><em>Halozyme’s orientation as a <u>commercialization company rather than a development company led to the passing of the Tlando XR (LPCN 1111) option</u>. <u>Tlando XR is now available for partnering</u>. <u>Lipocine is working with a contract manufacturer for the scale-up and manufacturing of LPCN 1111 and has completed a technology transfer to this end</u>. <u>Lipocine will not develop the product any further but is seeking a partner to do so and preparing for an efficient handoff with the product ready for clinical trials</u>.</em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 231785, member: 13851"] Going to be a while! [URL unfurl="true"]https://wfn1.com/financial-news/columns/zacks-research/lpcn-tlando-launched/[/URL] [B]TLANDO[/B] [I]Tlando was launched by partner [URL='https://halozyme.com/']Halozyme[/URL] during the second quarter, which acquired original license holder Antares Pharma in May 2022. Halozyme announced the launch of the product in a June 7th [URL='https://ir.halozyme.com/news/news-details/2022/Halozyme-Announces-Commercial-Launch-of-TLANDO-an-Oral-Treatment-for-Testosterone-Replacement-Therapy/default.aspx']press release [/URL]and plans to commercialize Tlando along with Antares’ injectable testosterone replacement therapy Xyosted. [/I][B][I]Halozyme’s orientation as a [U]commercialization company rather than a development company led to the passing of the Tlando XR (LPCN 1111) option[/U]. [U]Tlando XR is now available for partnering[/U]. [U]Lipocine is working with a contract manufacturer for the scale-up and manufacturing of LPCN 1111 and has completed a technology transfer to this end[/U]. [U]Lipocine will not develop the product any further but is seeking a partner to do so and preparing for an efficient handoff with the product ready for clinical trials[/U].[/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
TLANDO & TLANDO XR - novel oral prodrugs of testosterone
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top